Gessner T, Vaughan L A, Beehler B C, Bartels C J, Baker R M
Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263.
Cancer Res. 1990 Jul 1;50(13):3921-7.
Anthracycline resistance of P388 daunorubicin-resistant cells cannot be accounted for merely by differences in drug uptake and retention; protection against intracellular drug was also indicated. Cytotoxicity of daunorubicin may be partially due to the formation of free radicals and reactive oxygen species (hydrogen peroxide, hydroxyl radical, singlet oxygen, and superoxide anion radical). Protection against free radicals and peroxides is largely dependent upon the availability of reduced glutathione, which in turn requires NADPH for its continual regeneration. Pentose phosphate cycle (also called hexose monophosphate shunt) is known to provide NADPH for maintenance of glutathione. Activities of the two NADPH-producing dehydrogenases of the cycle, glucose-6-phosphate and 6-phosphogluconate dehydrogenase, were 40% higher (P less than 0.05) and activity of the cycle in intact cells was 2-fold higher in the resistant than the sensitive cells. The cycle was as active in these cells as it is known to be in macrophages, indicating a very effective protection against oxidative stress, free radicals, and alkylating electrophiles. Elevated activity of the pentose phosphate pathway in drug-resistant cells can represent a mechanism of resistance against multiple structurally unrelated drugs. Efflux of daunorubicin may be aided by further metabolism to glucuronides. Daunorubicinol, a known active metabolite of daunorubicin, can be metabolized to a glucuronide by the cells and eliminated into the surrounding medium. Glucuronidation of daunorubicinol was evidenced by (a) release of daunorubicinol following glucuronidase hydrolysis of media from cell incubations with 1.8 microM daunorubicin and (b) production of radioactive glucuronide when cell homogenates were incubated with UDP-[14C]glucuronic acid plus daunorubicinol. Glucuronyltransferase activity with a broad substrate specificity was found in the cells. Using model substrates, 1-naphthol and o-aminophenol, it was determined that glucuronyltransferase activity was 4 times higher in daunorubicin-resistant than -sensitive P388 cells. Elevated glucuronyltransferase could contribute to daunorubicin and multidrug resistance.
P388柔红霉素耐药细胞对蒽环类药物的耐药性不能仅通过药物摄取和潴留的差异来解释;细胞内药物保护作用也有体现。柔红霉素的细胞毒性可能部分归因于自由基和活性氧(过氧化氢、羟基自由基、单线态氧和超氧阴离子自由基)的形成。对自由基和过氧化物的保护很大程度上取决于还原型谷胱甘肽的可用性,而还原型谷胱甘肽的持续再生又需要NADPH。已知磷酸戊糖途径(也称为己糖磷酸旁路)可提供NADPH以维持谷胱甘肽。该途径中两种产生NADPH的脱氢酶,即葡萄糖-6-磷酸脱氢酶和6-磷酸葡萄糖酸脱氢酶的活性,在耐药细胞中比敏感细胞高40%(P小于0.05),完整细胞中该途径的活性在耐药细胞中比敏感细胞高2倍。该途径在这些细胞中的活性与已知在巨噬细胞中的活性一样高,表明对氧化应激、自由基和烷基化亲电试剂具有非常有效的保护作用。耐药细胞中磷酸戊糖途径活性升高可能代表对多种结构不相关药物的耐药机制。柔红霉素进一步代谢为葡糖醛酸苷可能有助于其外排。柔红霉素醇是柔红霉素的一种已知活性代谢产物,可被细胞代谢为葡糖醛酸苷并排泄到周围培养基中。柔红霉素醇的葡糖醛酸化表现为:(a)用1.8μM柔红霉素进行细胞培养后,培养基经葡糖醛酸酶水解后释放出柔红霉素醇;(b)细胞匀浆与UDP-[14C]葡糖醛酸加柔红霉素醇一起孵育时产生放射性葡糖醛酸苷。在细胞中发现了具有广泛底物特异性的葡糖醛酸转移酶活性。使用模型底物1-萘酚和邻氨基酚测定,柔红霉素耐药的P388细胞中的葡糖醛酸转移酶活性比敏感细胞高4倍。葡糖醛酸转移酶活性升高可能导致对柔红霉素和多药耐药。